Virus-mediated gene delivery for human gene therapy

Area of Science:

• Biotechnology
• Molecular Biology
• Genetics

Background:

• Gene therapy has evolved significantly since its inception over two decades ago.
• Early challenges in clinical gene transfer have been progressively addressed.
• Viral vectors are the predominant tools for nucleic acid delivery in gene therapy.

Purpose of the Study:

• To review the current state of viral gene transfer in clinical applications.
• To highlight the molecular characteristics of major viral vector classes.
• To summarize findings from gene therapy clinical trials utilizing viral vectors.

Main Methods:

• Review of existing literature on gene therapy clinical trials.
• Analysis of molecular properties of commonly used viral vectors.
• Synthesis of data from in vivo and ex vivo gene transfer studies.

Main Results:

• Viral vectors demonstrate high efficiency in nucleic acid delivery for gene therapy.
• Diverse viral vector systems are employed in ongoing clinical trials.
• Clinical trial data provide insights into the safety and efficacy of viral gene transfer.

Conclusions:

• Gene therapy, particularly using viral vectors, is a clinically viable and advancing field.
• Understanding viral vector properties is crucial for successful gene therapy applications.
• Continued research and clinical trials are essential for further progress in gene therapy.